Jade Biosciences, Inc.

JBIO · Nasdaq · SIC 2834: Pharmaceutical Preparations
82
SEC Filings

Business Summary

PART I Item 1. B usiness. Company Overview We are a clinical-stage biopharmaceutical company developing novel biologic therapies for patients living with autoimmune diseases. Our goal is to improve meaningfully upon the existing treatment paradigm through the delivery of improved dosing and convenience, a comparable safety profile, and potentially increased clinical activity. Our approach is to discover and efficiently develop biologics that address emerging targets supported by third-party clin...

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionJBIOdiscussed_in_filing Cybersecurity
topic_mentionJBIOdiscussed_in_filing Cybersecurity
topic_mentionJBIOdiscussed_in_filing Healthcare & Bio
topic_mentionJBIOdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-062025-12-310001193125-26-096550EDGAR—
2025-03-272024-12-310001558370-25-003750EDGAR—
2024-03-252023-12-310001798749-24-000015EDGAR—
2023-03-292022-12-310001798749-23-000015EDGAR—
2022-03-302021-12-310001493152-22-008189EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001193125-25-281525EDGAR62K words
2025-08-132025-06-300001193125-25-179853EDGAR—
2025-04-252025-03-310001558370-25-005564EDGAR—
2024-11-122024-09-300001798749-24-000059EDGAR—
2024-08-122024-06-300001798749-24-000049EDGAR—
2024-05-132024-03-310001558370-24-007985EDGAR—
2023-11-132023-09-300001798749-23-000060EDGAR—
2023-08-142023-06-300001798749-23-000056EDGAR—
2023-05-152023-03-310001798749-23-000039EDGAR—
2022-11-142022-09-300001558370-22-017586EDGAR—
2022-08-152022-06-300001493152-22-022598EDGAR—
2022-05-162022-03-310001493152-22-013523EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001193125-26-140091EDGAR1K words
2026-03-060001193125-26-094967EDGAR—
2026-01-050001193125-26-001502EDGAR—
2025-12-150001193125-25-318436EDGAR—
2025-11-140001193125-25-281498EDGAR—
2025-10-070001193125-25-232562EDGAR—
2025-09-090001193125-25-198777EDGAR—
2025-08-130001193125-25-179828EDGAR—
2025-07-010001193125-25-153427EDGAR—
2025-05-140001193125-25-119856EDGAR—

82 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001798749
TickerJBIO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b49506c9005bca394b3e2ca12b134727b95b1ee7f15aaf9e6231709db2b0e416
parent: d6c9e6b80ecf31a13c6ccb8154e2acf7c02188763f9ddbbba4545bbb0e29396f
content hash: f0f1a4edc218f4a8e1f8a3571a25d294979d2cfb9e9d45c24b8e6c837c77317a
signed: 2026-04-13T04:45:47.767Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf